BioCentury | Jun 7, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: May 2018

...interaction could help treat social isolation syndrome. California Institute of Technology Distillery Therapeutics Alzheimer’s disease Inositol 1,4,5-trisphosphate receptor type 2 (ITPR2)...
BioCentury | May 23, 2018
Distillery Therapeutics

Neurology

...inhibition in additional models of AD. TARGET/MARKER/PATHWAY: Purinergic receptor P2Y G protein-coupled 1 (P2RY1; P2Y1); inositol 1,4,5-trisphosphate receptor type 2 (ITPR2)...
...doi:10.1084/jem.20171487 CONTACT: Gabor C. Petzold, German Center for Neurodegenerative Diseases, Bonn, Germany email: gabor.petzold@dzne.de Hongjiang Li Helmholtz Association Inositol 1,4,5-trisphosphate receptor type 2 (ITPR2) Purinergic...
Items per page:
1 - 2 of 2